ASRT Stock Analysis: Buy, Sell, or Hold?
ASRT - Assertio Holdings, Inc. Common Stock
$23.47
0.02 (0.09%)
▲
5d:
+0.26%
30d:
+8.61%
90d:
+94.45%
BUY
MODERATE Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Get Alerted When ASRT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ASRT shows positive signals but monitor for confirmation. Market pricing in 9.7% growth. Moderate conviction.
💡 BUY OPPORTUNITY: ASRT shows positive signals but monitor for confirmation. Market pricing in 9.7% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$24.94
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$15.49
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 6.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ASRT is currently trading at $23.47, which is considered slightly high relative to its 30-day fair value range of $20.20 to $24.09. From a valuation perspective, the stock is trading at a premium (Forward PE: 9.1) compared to its historical average (6.9). At these levels, the market is pricing in 9.7% annual earnings growth.
Technical Outlook: Technically, ASRT is in a strong uptrend. The price is currently testing key support at $23.36. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ASRT is in a strong uptrend. The price is currently testing key support at $23.36. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$20.20 -
$24.09
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.8%
All Signals
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($24.43)
- BULLISH: Expecting earnings turnaround to 9.7% growth with -62.5% revenue growth
Trading Range Analysis
30-Day Trading Range
$20.20 -
$24.09
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$23.36
Resistance Level
$23.47
Current Trend
Strong Uptrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.10
Wall Street Target
$24.43
(+4.1%)
Revenue Growth (YoY)
-62.5%
Earnings Growth (YoY)
-18.8%
Profit Margin
-34.9%
Valuation Premium vs History
+9.7% premium
PE vs Historical
9.1 vs 6.9
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+9.7%
(market-implied from PE analysis)
1-Year Target
$25.75
(+10%)
2-Year Target
$28.24
(+20%)
3-Year Target
$30.98
(+32%)
3-Yr Target (if PE normalizes)
(PE: 9→7)
PE COMPRESSION
$23.50
(+0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: June 03, 2026 10:06 PM ET
Data refreshes hourly during market hours. Next update: 11:06 PM
Data refreshes hourly during market hours. Next update: 11:06 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ASRT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$192 | 66 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 60 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$104 | 56 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 58 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$23 | 55 HOLD |
